Cargando…

Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon

INTRODUCTION: The genetic admixture of the Brazilian population has considerable relevance to the implementation of the principles of pharmacogenomics (PGx), as it may compromise the extrapolation of data obtained in more homogeneous world populations. PURPOSE: This study aims to investigate a panel...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Marianne Rodrigues, Rodrigues, Juliana Carla Gomes, Maroñas, Olalla, Latorre-Pellicer, Ana, Cruz, Raquel, Guerreiro, João Farias, Burbano, Rommel Mario Rodriguez, de Assumpção, Paulo Pimentel, Ribeiro-dos-Santos, Andrea, dos Santos, Sidney Emanuel Batista, Carracedo, Angel, dos Santos, Ney Pereira Carneiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837547/
https://www.ncbi.nlm.nih.gov/pubmed/33519226
http://dx.doi.org/10.2147/PGPM.S274741
_version_ 1783642976318128128
author Fernandes, Marianne Rodrigues
Rodrigues, Juliana Carla Gomes
Maroñas, Olalla
Latorre-Pellicer, Ana
Cruz, Raquel
Guerreiro, João Farias
Burbano, Rommel Mario Rodriguez
de Assumpção, Paulo Pimentel
Ribeiro-dos-Santos, Andrea
dos Santos, Sidney Emanuel Batista
Carracedo, Angel
dos Santos, Ney Pereira Carneiro
author_facet Fernandes, Marianne Rodrigues
Rodrigues, Juliana Carla Gomes
Maroñas, Olalla
Latorre-Pellicer, Ana
Cruz, Raquel
Guerreiro, João Farias
Burbano, Rommel Mario Rodriguez
de Assumpção, Paulo Pimentel
Ribeiro-dos-Santos, Andrea
dos Santos, Sidney Emanuel Batista
Carracedo, Angel
dos Santos, Ney Pereira Carneiro
author_sort Fernandes, Marianne Rodrigues
collection PubMed
description INTRODUCTION: The genetic admixture of the Brazilian population has considerable relevance to the implementation of the principles of pharmacogenomics (PGx), as it may compromise the extrapolation of data obtained in more homogeneous world populations. PURPOSE: This study aims to investigate a panel of 117 polymorphisms in 35 pharmacogenes, which contains label recommendations or clinical evidence by international drug regulatory agencies, in Amazonian Native American populations, and compare the results obtained with continental population data from the 1000 Genomes Project Consortium. PATIENTS AND METHODS: The study population is composed of 109 Native American individuals from three Brazilian Amazon groups. The genotyping of the PGx polymorphisms was performed by allelic discrimination using TaqMan(®) OpenArray Genotyping with a panel of 120 customized assays on the QuantStudio™ 12K Flex Real-Time PCR System. RESULTS: Statistical differences within the Native American populations were observed regarding both genotypes and phenotypes of some genes of the CYP family. The discriminant analysis of principal components (DAPCs) between the NAM group and the continental populations of the 1000 Genomes Project resulted in the clustering of the three Native American populations. Additionally, in general, the NAM group was determined to be closely situated between East Asia, America, and South Asia groups, which enabled us to infer a genetic similarity between these populations. The DAPC analysis further demonstrated that eight polymorphisms and six polymorphisms were more relevant in differentiating the NAM from the continental populations and the NAM populations among themselves, respectively. CONCLUSION: Some investigated polymorphisms show differences among world populations, particularly with populations of European origin, for whom precision medicine protocols are primarily designed. The accumulated knowledge regarding these variations may assist in the design of specific protocols for Native American populations and populations admixed with them.
format Online
Article
Text
id pubmed-7837547
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78375472021-01-28 Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon Fernandes, Marianne Rodrigues Rodrigues, Juliana Carla Gomes Maroñas, Olalla Latorre-Pellicer, Ana Cruz, Raquel Guerreiro, João Farias Burbano, Rommel Mario Rodriguez de Assumpção, Paulo Pimentel Ribeiro-dos-Santos, Andrea dos Santos, Sidney Emanuel Batista Carracedo, Angel dos Santos, Ney Pereira Carneiro Pharmgenomics Pers Med Original Research INTRODUCTION: The genetic admixture of the Brazilian population has considerable relevance to the implementation of the principles of pharmacogenomics (PGx), as it may compromise the extrapolation of data obtained in more homogeneous world populations. PURPOSE: This study aims to investigate a panel of 117 polymorphisms in 35 pharmacogenes, which contains label recommendations or clinical evidence by international drug regulatory agencies, in Amazonian Native American populations, and compare the results obtained with continental population data from the 1000 Genomes Project Consortium. PATIENTS AND METHODS: The study population is composed of 109 Native American individuals from three Brazilian Amazon groups. The genotyping of the PGx polymorphisms was performed by allelic discrimination using TaqMan(®) OpenArray Genotyping with a panel of 120 customized assays on the QuantStudio™ 12K Flex Real-Time PCR System. RESULTS: Statistical differences within the Native American populations were observed regarding both genotypes and phenotypes of some genes of the CYP family. The discriminant analysis of principal components (DAPCs) between the NAM group and the continental populations of the 1000 Genomes Project resulted in the clustering of the three Native American populations. Additionally, in general, the NAM group was determined to be closely situated between East Asia, America, and South Asia groups, which enabled us to infer a genetic similarity between these populations. The DAPC analysis further demonstrated that eight polymorphisms and six polymorphisms were more relevant in differentiating the NAM from the continental populations and the NAM populations among themselves, respectively. CONCLUSION: Some investigated polymorphisms show differences among world populations, particularly with populations of European origin, for whom precision medicine protocols are primarily designed. The accumulated knowledge regarding these variations may assist in the design of specific protocols for Native American populations and populations admixed with them. Dove 2021-01-22 /pmc/articles/PMC7837547/ /pubmed/33519226 http://dx.doi.org/10.2147/PGPM.S274741 Text en © 2021 Fernandes et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Fernandes, Marianne Rodrigues
Rodrigues, Juliana Carla Gomes
Maroñas, Olalla
Latorre-Pellicer, Ana
Cruz, Raquel
Guerreiro, João Farias
Burbano, Rommel Mario Rodriguez
de Assumpção, Paulo Pimentel
Ribeiro-dos-Santos, Andrea
dos Santos, Sidney Emanuel Batista
Carracedo, Angel
dos Santos, Ney Pereira Carneiro
Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon
title Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon
title_full Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon
title_fullStr Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon
title_full_unstemmed Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon
title_short Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon
title_sort genetic diversity of drug-related genes in native americans of the brazilian amazon
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837547/
https://www.ncbi.nlm.nih.gov/pubmed/33519226
http://dx.doi.org/10.2147/PGPM.S274741
work_keys_str_mv AT fernandesmariannerodrigues geneticdiversityofdrugrelatedgenesinnativeamericansofthebrazilianamazon
AT rodriguesjulianacarlagomes geneticdiversityofdrugrelatedgenesinnativeamericansofthebrazilianamazon
AT maronasolalla geneticdiversityofdrugrelatedgenesinnativeamericansofthebrazilianamazon
AT latorrepellicerana geneticdiversityofdrugrelatedgenesinnativeamericansofthebrazilianamazon
AT cruzraquel geneticdiversityofdrugrelatedgenesinnativeamericansofthebrazilianamazon
AT guerreirojoaofarias geneticdiversityofdrugrelatedgenesinnativeamericansofthebrazilianamazon
AT burbanorommelmariorodriguez geneticdiversityofdrugrelatedgenesinnativeamericansofthebrazilianamazon
AT deassumpcaopaulopimentel geneticdiversityofdrugrelatedgenesinnativeamericansofthebrazilianamazon
AT ribeirodossantosandrea geneticdiversityofdrugrelatedgenesinnativeamericansofthebrazilianamazon
AT dossantossidneyemanuelbatista geneticdiversityofdrugrelatedgenesinnativeamericansofthebrazilianamazon
AT carracedoangel geneticdiversityofdrugrelatedgenesinnativeamericansofthebrazilianamazon
AT dossantosneypereiracarneiro geneticdiversityofdrugrelatedgenesinnativeamericansofthebrazilianamazon